Triangle biotech startup focusing on depression disorder raises $45M

Arrivo BioVentures, which emerged from stealth mode less than two years ago with $49 million in funding and four drug candidates, has raised another $45 million and plans to advance its treatment focused on major depression disorder or MDD.

Related Keywords

, Rex Health Ventures , Solas Bioventures Emerging Healthcare Fund , Orlando Health Ventures , Arrivo Bioventures , Triangle Based Rex Health , Steve Butts ,